and patients with glutathione-S-transferase M1 (proinflammatory-cytokine producer macrophages) null and M1 and T1 (Type 1 helper CD4 + lymphocytes) double null polymorphisms had increased mortality suggesting that antioxidant therapy becomes fundamental for those patients (109)
He W, Kapate N, Shields CWT, Mitragotri S
Generally, candidates for prescription weight loss support have a BMI of 30 or higher (obesity) or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
A personalized evaluation can determine which medical weight loss approach best aligns with individual health factors and long-term wellness goals
[1] [2] The medication works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite